Cardiac Biomarkers Market, Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

Report Description

Global Cardiac Biomarkers Market is expected to grow at a CAGR of 9.6% from 2017 to 2025. The report highlights the key trends, market outlook and the global scenario of the Global Cardiac Biomarkers Market. The market sizing is provided from 2016 to 2025, wherein the forecast is provided from 2017 to 2025. In addition, market dynamics (i.e. market drivers, market restraints and market opportunities) which covers factors supporting the market growth, factors restraining the market growth and factors behind the opportunities across this industry in the coming years has been included extensively under the scope of the study. The report also provides extensive detail of the market segments across type, application, and geography; market share of the key players globally and the competitive scenario throughout the forecast period, industry expert opinion, and profiles of the key players in the market. The major key players of the market are as follows:

KEY PLAYERS

ABBOTT LABORATORIES

ACS BIOMARKER BV

BECKMAN COULTER (PART OF DANAHER)

BG MEDICINE INC.

BIOMERIEUX S.A.

BIO-RAD LABORATORIES INC.

CARDIOGENICS

CAVADIS

CRITICAL DIAGNOSTICS

CRUINN MEDICAL LTD.

HEALTH-CHEM DIAGNOSTICS

LIFE DIAGNOSTICS INC.

LIFESIGN

LSI MEDIENCE CORP.

MERIDIAN LIFE SCIENCE INC.

METANOMICS HEALTH GMBH

MIRNEXT

ORTHO-CLINICAL DIAGNOSTICS INC.

PTS DIAGNOSTICS

RADIOMETER MEDICAL APS

RANDOX LABORATORIES LTD.

RESPONSE BIOMEDICAL CORP.

ROCHE (FORMERLY HOFFMANN-LA ROCHE LTD.)

SANYO CHEMICAL INDUSTRIES LTD.

SIEMENS AG

SINGULEX INC.

SPECTRAL MEDICAL, INC.

THERMO FISHER SCIENTIFIC

TOSOH BIOSCIENCE INC.

TRINITY BIOTECH PLC

ZENOSENSE INC.

Scope of the Market

Type Market

Geography Market

North America

Europe

Asia Pacific

Rest of the World (RoW

Back to top

Payment Options

Single User : $3897 $2,923
Five User: $ 5175
$3,881
Enterprise : $ 9135 $6,851